ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,248Medicare Part D Prescriptions Filled, Including Refills

Rank: 416 out of 6969

$394K Total Retail Price of All Prescriptions

Rank: 973 out of 6969

275 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

49% of this provider’s 275 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 678 396 S3 1 3
ACETAMINOPHEN-CODEINE 460 277 S3 2 73
AMLODIPINE BESYLATE 452 329 3 4
TRAMADOL HCL 300 175 4 27
FUROSEMIDE 230 192 5 10
METFORMIN HCL 214 162 6 7
OMEPRAZOLE 200 116 7 6
IBUPROFEN 199 112 8 29
HYDROCHLOROTHIAZIDE 198 122 9 8
TRIAMCINOLONE ACETONIDE 190 125 10 55
DIOVAN HCT 177 133 11 57
SIMVASTATIN 167 127 12 1
DIOVAN 163 112 13 26
AZITHROMYCIN 142 84 14 42
GABAPENTIN 142 83 14 17
BENAZEPRIL HCL 141 112 16 18
CARISOPRODOL 139 35 R 17 69
POTASSIUM CHLORIDE 138 94 18 30
PROAIR HFA 137 97 19 33
NAPROXEN 130 87 20 62
LISINOPRIL 116 113 21 2
RANITIDINE HCL 104 81 22 46
AMPICILLIN TRIHYDRATE 101 88 23 284
VENTOLIN HFA 92 51 24 125
HYDROXYZINE HCL 91 25 R 25 159
ZOLPIDEM TARTRATE 88 53 26 16
ATORVASTATIN CALCIUM 85 68 27 11
ATENOLOL 83 83 28 9
PHENYTOIN SODIUM EXTENDED 76 56 29 169
AMOXICILLIN 75 46 30 99
BUSPIRONE HCL 74 58 31 187
KLOR-CON 8 73 51 32 104
ADVAIR DISKUS 73 41 32 45
DIPHENOXYLATE-ATROPINE 72 25 34 214
AMLODIPINE BESYLATE-BENAZEPRIL 69 45 35 91
CEPHALEXIN 68 28 36 96
CARVEDILOL 68 32 36 25
LOSARTAN POTASSIUM 67 33 38 12
FLUTICASONE PROPIONATE 66 33 39 24
ALBUTEROL SULFATE 66 42 39 123
LEVOTHYROXINE SODIUM 62 56 41 5
AMITRIPTYLINE HCL 62 32 R 41 87
HYDROCORTISONE 62 14 41 218
TRIAMTERENE-HYDROCHLOROTHIAZID 60 48 44 168
METOPROLOL TARTRATE 59 48 45 13
SULINDAC 59 41 45 267
LOSARTAN-HYDROCHLOROTHIAZIDE 59 31 45 53
CLONIDINE HCL 57 19 48 59
BACLOFEN 56 44 49 86
PERPHENAZINE-AMITRIPTYLINE 55 35 R 50 498
NABUMETONE 54 38 51 209
SINGULAIR 53 30 52 84
PROCHLORPERAZINE MALEATE 52 35 53 328
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.